Potency Levels
Potency refers to the relative strength of a mushroom’s active compounds. Different strains can contain varying levels of psilocybin and psilocin, which influence the overall intensity of the experience.
Our mushrooms are categorized into three general potency levels to help guide your selection. Individual experiences may still vary depending on dosage, environment, and personal sensitivity.
Strain Characteristics
Each mushroom strain has unique genetic traits and growth characteristics that shape its overall experience profile.
To make selection easier, every strain is assigned to one of three distinct experience categories: Uplifting, Balanced, or Deep. These categories reflect the general character of the journey most commonly associated with each strain.
Vendor: EDEN
Penis Envy #6 Magic Mushrooms
Vendor: EDEN
Penis Envy EXTREME Magic Mushrooms
Vendor: EDEN
Enigma Envy Magic Mushrooms
Vendor: EDEN
Clockwork Orange Magic Mushrooms
Vendor: EDEN
Albino Melmac Magic Mushrooms
Vendor: EDEN
Squat Mak Magic Mushrooms
Vendor: EDEN
White Wizard Magic Mushrooms
Vendor: EDEN
Bluey Vuitton Magic Mushrooms
Vendor: EDEN
Ecuadorian Magic Mushrooms
Vendor: EDEN
Tsunami Crest Magic Mushrooms
Browse More Mushrooms
Info Hub
Can Psilocybin Help Unlock Lost Memories? The Alzheimer's Story Raising New Questions
What if a memory isn't gone? What if it's still there - but simply difficult to reach? Imagine watching a loved one slowly lose their ability to communicate. Conversations become shorter. Memories fade. Moments of connection become increasingly rare. Then one day, seemingly out of nowhere, they begin speaking in complete sentences. They recall stories. They laugh. They make eye contact. For a brief moment, the person you remember feels present again. That's why a recently published Alzheimer's case report has captured attention throughout both the scientific and psychedelic communities. Not because researchers believe they've discovered a cure. They haven't. But because they observed something that challenges long-held assumptions about memory, neurodegeneration, and the brain's ability to adapt. And that may be the most fascinating part of the story. The Story That Sparked New Questions The participant was an 80-year-old woman living with advanced Alzheimer's disease. According to the published report, she had experienced nearly a decade of progressive cognitive decline, relying heavily on caregivers as communication, independence, and daily functioning gradually deteriorated. Like millions of families navigating dementia, her loved ones had watched memory, connection, and personality slowly fade over time. Then something unexpected happened. Following a high-dose psilocybin experience, caregivers began noticing changes—not immediately, but within the following day. Researchers documented improvements in speech, emotional expression, social engagement, eye contact, mobility, memory recall, and even urinary continence. Caregivers reported that she began speaking in complete sentences, recalling personal memories, laughing, and engaging with people around her in ways they had not witnessed for years. Importantly, researchers did not describe these observations as a cure or reversal of Alzheimer's disease. The underlying disease remained, and the improvements were temporary. Yet the changes were significant enough to spark new scientific curiosity. Because if the disease itself wasn't reversed, what exactly was happening? Why This Story Is Getting Attention Case reports rarely change science on their own. But occasionally, a single observation raises questions important enough to spark broader investigation. That's what appears to be happening here. The Alzheimer's case has been discussed across psychedelic research circles and highlighted by educators, researchers, and clinicians interested in neuroplasticity and brain health. It arrives at a time when scientists are increasingly studying psilocybin's effects on neuroplasticity—the brain's ability to adapt, reorganize, and form new connections throughout life. The reason for the excitement isn't that anyone believes Alzheimer's disease has been cured. It's that the case touches on a much larger question: How adaptable is the human brain, even in the face of significant decline? Researchers don't have an answer yet. But many believe it's a question worth exploring. And for families affected by Alzheimer's disease, every meaningful question matters. Psilocybin and Alzheimer's: What Researchers Know Today Let's start with what researchers actually know. There is currently no evidence that psilocybin cures Alzheimer's disease. There is also no approved psychedelic treatment for Alzheimer's or dementia. Those facts are important. At the same time, researchers are becoming increasingly interested in how psilocybin influences brain connectivity, cognitive flexibility, emotional processing, learning, and neural communication. Why? Because many of those same systems are deeply connected to memory and cognition. Scientists are exploring whether compounds that temporarily increase communication between different brain networks might help us better understand how memories are accessed, stored, and expressed. The science remains early. But the questions are growing. And in science, good questions often come before meaningful discoveries. The Neuroplasticity Connection One word appears again and again throughout modern psychedelic research: Neuroplasticity. Neuroplasticity refers to the brain's ability to adapt and reorganize itself throughout life. For decades, scientists believed the adult brain was largely fixed. Today, we know that's not true. The brain continues forming new connections, strengthening pathways, and adapting to new experiences well into old age. Research suggests psilocybin may temporarily increase communication between different brain regions while loosening some of the rigid patterns that normally shape thought and behavior. This doesn't mean psilocybin repairs damaged brain tissue, nor does it mean researchers have discovered a treatment for Alzheimer's disease. What it does raise is a fascinating possibility: Could the brain be more adaptable than we once believed? And if so, what does that mean for memory? These are exactly the kinds of questions researchers are now beginning to explore. Memory May Be More Complex Than We Think Most people think of memory as storage. Something is either there or it isn't. But neuroscience paints a more complicated picture. Remembering requires communication between multiple brain systems. Attention, language, emotion, recognition, and context all work together. Memory isn't stored in a single location. It's the product of a network. Increasingly, researchers recognize that memory challenges aren't always about information disappearing entirely. Sometimes they involve access. That's one reason stories like this attract so much attention. Not because they prove lost memories returned. But because they suggest the relationship between memory and access may be far more nuanced than we once believed. If certain pathways become less accessible over time, could increased neural connectivity temporarily change that equation? No one knows yet. But it's a fascinating possibility. Why This Matters Beyond One Patient It's easy to look at a case report like this and focus on the individual story. An elderly woman. A temporary improvement. A surprising observation. But researchers are interested in something much larger. For decades, Alzheimer's research has focused primarily on slowing decline. This case report doesn't change that reality. But it does introduce a different question: What if understanding the aging brain isn't only about what is being lost? What if it's also about understanding what remains? Researchers still don't know whether the observations documented in this case can be reproduced. They don't know whether similar effects would appear in other patients. And they certainly don't know whether psilocybin will ever play a meaningful role in Alzheimer's care. What they do know is that the case challenges assumptions. And science often moves forward when assumptions are challenged. In that sense, the significance of this report may extend beyond the participant herself. It's another example of how psychedelic science is evolving from a conversation about possibilities into a conversation guided by evidence, observation, and rigorous research. That's a meaningful step forward - not just for psychedelic research, but for neuroscience as a whole. A Bigger Question About Human Potential Perhaps the most compelling part of this story has nothing to do with Alzheimer's disease specifically. It has to do with how we think about the human brain. For much of modern history, many neurological conditions were viewed almost entirely through the lens of decline. Today, neuroscience increasingly focuses on adaptability. Resilience. Plasticity. Change. Stories like this remind us that the brain remains one of the most complex systems ever studied. Even in situations where significant challenges exist, surprising observations continue to emerge. That doesn't mean every observation becomes a breakthrough. And it certainly doesn't mean every observation becomes a treatment. But it does mean there is still much we don't understand. And that's exactly what makes this research so fascinating. The Bottom Line Can psilocybin cure Alzheimer's disease? Current evidence says no. Can a single case report prove that psilocybin restores memory? No. But it can do something equally important. It can point researchers toward new questions. Questions about neuroplasticity. Brain connectivity. Memory access. Adaptation. And the remarkable flexibility of the human nervous system. The publication of this case report—and the attention it has received throughout the psychedelic research community—reflects growing interest in how psilocybin may influence cognition, brain connectivity, and neuroplasticity. The most fascinating part of this story isn't that scientists found answers. It's that they discovered a question they didn't expect to ask. And that's often where meaningful discoveries begin. If you're interested in learning more about psilocybin, neuroplasticity, and the emerging science behind these compounds, explore EDEN's mushroom collection and educational resources to continue your research journey. Continue Exploring Psilocybin Beyond Mental Health: What Scientists Are Learning About the Brain, Body, and Human Potential Frequently Asked Questions Did psilocybin cure Alzheimer's disease? No. Researchers did not describe the case as a cure or reversal of Alzheimer's disease. The improvements observed were temporary and occurred within a single documented case. Why has this Alzheimer's case received so much attention? The participant experienced temporary improvements in communication, memory recall, emotional expression, and social engagement, raising important questions about brain adaptability and neuroplasticity. What is neuroplasticity? Neuroplasticity is the brain's ability to adapt, reorganize, and form new neural connections throughout life. It plays a critical role in learning, memory, and recovery. Are scientists studying psilocybin and memory? Yes. Researchers are investigating how psilocybin affects brain connectivity, cognitive flexibility, memory systems, and neuroplasticity. Can psilocybin improve memory? There is currently no evidence that psilocybin reliably improves memory or treats Alzheimer's disease. However, scientists continue studying how psychedelic compounds influence cognition and neural communication. Why are researchers interested in brain connectivity? Memory, learning, and cognition depend on communication between multiple brain regions. Understanding how psilocybin influences these networks may help researchers better understand how the brain adapts and functions. What makes this case different? The observations extended beyond memory and included communication, emotional expression, social engagement, mobility, and awareness, making it a particularly intriguing case for researchers. Scientific Sources & Further Reading Original Case Report Frontiers in Neuroscience: Advanced Alzheimer's Disease and Psilocybin Case Report Additional Analysis The Focal Points Alzheimer's Case Summary Research Institutions Johns Hopkins Center for Psychedelic and Consciousness Research Imperial College Centre for Psychedelic Research Yale School of Medicine Psychedelic Science Program National Institute on Aging National Institutes of Health (NIH)
Learn more
Psilocybin Beyond Mental Health: What Scientists Are Learning About the Brain, Body, and Human Potential
For years, nearly every conversation about psilocybin revolved around mental health. Depression. Anxiety. PTSD. Addiction. And for good reason. Some of the most promising psychedelic research of the past decade has focused on helping people navigate emotional suffering and improve psychological well-being. But something interesting is happening. As researchers continue studying psilocybin, they're beginning to ask much bigger questions. Not just whether it can influence mood, but whether it may affect some of the fundamental systems that help humans learn, adapt, recover, and change. How does the brain form new pathways? Can perception influence movement? What role does neuroplasticity play in memory, pain, aging, and resilience? The answers remain far from settled. Yet the scope of the questions is expanding rapidly. Today's psychedelic research is no longer focused exclusively on mental health. Increasingly, scientists are exploring how psilocybin may interact with some of the deepest mechanisms involved in human adaptation itself. The Shift From Mental Health to Neuroplasticity If there is one word driving the next generation of psychedelic research, it's neuroplasticity. Neuroplasticity refers to the brain's ability to adapt, reorganize, and form new connections throughout life. For decades, scientists believed the adult brain was largely fixed. Today, we know the opposite is true. The brain is constantly changing in response to learning, habits, experiences, injury, environment, and age. Every skill we develop, every memory we form, and every behavior we repeat leaves its mark on the neural pathways that shape our lives. This is one reason psilocybin has captured so much scientific interest. Research suggests psilocybin may temporarily increase communication between different regions of the brain while loosening some of the rigid patterns that influence how we think, feel, and perceive the world. Scientists continue to investigate exactly how these mechanisms work, but the implications are difficult to ignore. For years, much of the conversation centered on mental health. Today, researchers are exploring a broader possibility: that psilocybin's effects on neuroplasticity may have implications that extend far beyond mood alone. That single question sits at the center of nearly every emerging area of psychedelic science. Why Adaptability Matters For much of modern medical history, many neurological conditions were viewed through the lens of decline. If a function was lost, the assumption was often that it could not return. Modern neuroscience is gradually challenging that idea. Researchers now understand that the brain may be far more adaptable than previously believed. While there are still significant limits to what science knows, growing interest in neuroplasticity reflects a larger shift in thinking: the possibility that the brain remains capable of learning, adapting, and reorganizing throughout much more of life than once assumed. This shift has implications that extend well beyond mental health. It influences how scientists think about memory, recovery, movement, aging, and resilience itself. Memory, Learning, and Cognitive Function One of the most fascinating areas of emerging research involves memory. Recently, researchers documented a widely discussed case involving an elderly woman living with advanced Alzheimer's disease who experienced temporary improvements in communication, emotional expression, and memory recall following a psilocybin experience. Importantly, researchers did not describe the outcome as a cure. The disease remained. Yet the observations raised an intriguing question: Could certain neurological functions become more accessible under specific conditions, even when they appear diminished? No one knows the answer yet. However, studies examining neuroplasticity, cognitive flexibility, and brain connectivity continue to generate interest in how psychedelic compounds may interact with memory systems. As populations age and cognitive decline becomes an increasingly important public health challenge, this remains one of the most closely watched areas of psychedelic science. Related Reading: Can Psilocybin Help Unlock Lost Memories? The Alzheimer's Story Raising New Questions The Brain-Body Connection Most people think of movement as something physical. In reality, every movement begins in the brain. Every step, gesture, and muscle contraction depends on communication between the nervous system and the body. When those communication pathways become disrupted, symptoms can emerge that are often far more complex than simple structural damage alone. Researchers are increasingly interested in understanding how perception, neuroplasticity, and nervous system regulation influence movement itself. Stories have emerged of individuals reporting unexpected changes in mobility following psychedelic experiences. These accounts should not be viewed as evidence of treatment or recovery, but they raise important questions about how the brain controls, restricts, and potentially restores movement. If future research confirms meaningful connections, it could reshape how scientists think about adaptation, rehabilitation, and recovery. Chronic Pain: More Than a Physical Sensation Pain is often thought of as a physical problem. But pain is also deeply neurological. The brain constantly interprets signals from the body, deciding what deserves attention and how intensely sensations should be experienced. This is one reason chronic pain has become such an intriguing area of psychedelic research. Scientists are increasingly exploring whether psilocybin may influence the networks involved in pain perception, emotional processing, and self-awareness. The most interesting question isn't simply whether psilocybin affects pain. It's whether it changes how the brain experiences pain. That distinction could have profound implications for understanding long-term suffering and quality of life. Inflammation and the Immune System For years, inflammation was viewed primarily through a physical health lens. Today, researchers understand that chronic inflammation may influence a remarkably wide range of processes throughout the body, including those connected to mental and neurological well-being. While research remains in its early stages, scientists are beginning to explore whether psychedelic compounds interact with inflammatory pathways and immune system signaling. This doesn't mean psilocybin should be viewed as an anti-inflammatory treatment. Rather, it reflects a growing realization that the nervous system and immune system may be far more interconnected than previously believed. Understanding those connections could eventually reveal entirely new dimensions of how psychedelic compounds influence human biology. Brain Injury, Recovery, and Rehabilitation Another area attracting growing scientific interest is recovery after neurological injury. Whether caused by trauma, stroke, or other neurological events, recovery often depends on the brain's ability to create new pathways and compensate for damaged ones. Because neuroplasticity appears to play such a central role in these processes, researchers have become increasingly interested in understanding whether psychedelic compounds may have relevance within future rehabilitation frameworks. This remains an emerging field. No conclusions have been reached. Yet the possibility that psychedelic compounds could one day contribute to adaptive neurological processes continues to attract serious scientific attention. Why Cluster Headaches Captured Researchers' Attention Long before psychedelics entered mainstream conversations, people living with cluster headaches were already talking about them. Often described as one of the most painful conditions known in medicine, cluster headaches have generated decades of patient reports describing unexpected experiences following psilocybin use. Over time, the consistency of these reports attracted the attention of researchers. Today, cluster headaches remain one of the most frequently discussed neurological conditions in psychedelic science. It's a reminder that scientific discovery often begins with observations from real people searching for answers long before formal research catches up. Aging, Resilience, and the Future of Brain Health Perhaps the most compelling question of all is also the broadest: How does the brain maintain adaptability as we age? For much of modern history, aging was viewed primarily through the lens of decline. Today, researchers increasingly focus on resilience. What helps the brain remain flexible? What supports learning later in life? What preserves curiosity, adaptability, and cognitive function? Because neuroplasticity sits at the center of these questions, psychedelic research has naturally become part of the conversation. The goal isn't immortality. It's understanding how the brain continues learning, adapting, and evolving throughout the human lifespan. A New Way of Thinking About Psilocybin Perhaps the biggest shift happening in psychedelic science is this: Researchers are moving beyond the question of whether psilocybin affects depression or anxiety. Instead, they're asking a much larger question: How does psilocybin influence the brain's capacity to adapt? That single question connects nearly every emerging area of research. Memory. Movement. Pain. Inflammation. Recovery. Aging. Each represents a different expression of the same underlying process: The ability to change. And while many of the answers remain unknown, the questions themselves are reshaping how scientists think about the relationship between the brain, the body, and human potential. The Bottom Line Psilocybin is not a cure-all. Many of the questions researchers are asking today remain unanswered. Some areas of investigation may ultimately lead nowhere. Others could fundamentally reshape how we understand adaptation, learning, recovery, and resilience. What's clear is that the conversation has moved beyond mood alone. Scientists are now exploring how psilocybin interacts with some of the most fundamental systems involved in change itself. The most exciting thing about modern psychedelic science isn't that we've found all the answers. It's that we're finally beginning to ask better questions. As interest in psychedelic science continues to grow, education remains one of the most valuable tools available to consumers. Whether you're researching neuroplasticity, learning about microdosing, or comparing different mushroom strains, understanding the fundamentals can help you navigate this rapidly evolving field with greater confidence. To continue your exploration, you can browse our mushroom collection and educational resources for additional information on psilocybin products, strains, and emerging research. Continue Exploring Psychedelic science is evolving rapidly, and many of the most interesting questions are only beginning to be explored. If you'd like to dive deeper into specific areas of research, these are a great place to continue: Live now: Can Psilocybin Help Unlock Lost Memories? The Alzheimer's Story Raising New Questions Coming Soon: Can Psilocybin Help Restore Movement? What Science Says About Neuroplasticity and Paralysis Frequently Asked Questions Is psilocybin only being studied for mental health? No. While much of the research has focused on depression, anxiety, PTSD, and addiction, scientists are increasingly exploring how psilocybin may influence neuroplasticity, memory, movement, pain perception, inflammation, recovery, and aging. What is neuroplasticity? Neuroplasticity is the brain's ability to adapt, form new connections, and reorganize throughout life. It plays a critical role in learning, memory, recovery, and behavioral change. Can psilocybin increase neuroplasticity? Emerging research suggests psilocybin may influence mechanisms associated with increased brain connectivity and neuroplasticity. Researchers continue studying how these processes work. Can psilocybin improve memory? Scientists are actively studying how psilocybin affects memory and cognition. However, there is currently no evidence that psilocybin cures memory disorders such as Alzheimer's disease. Why are researchers interested in psilocybin and chronic pain? Researchers are exploring whether psilocybin may influence the way the brain interprets and responds to pain signals, potentially affecting the experience of chronic pain. What are cluster headaches? Cluster headaches are considered one of the most painful neurological conditions. Patient reports have encouraged researchers to investigate whether psychedelic compounds influence the biological pathways involved. Is psilocybin a cure-all? No. Psilocybin is not a cure-all, and many areas of research remain preliminary. The most exciting aspect of modern psychedelic science is the emergence of new questions about how the brain adapts, learns, and recovers.
Learn more
How Long Do Mushroom Edibles Take to Kick In? Timing, Onset & What to Expect
Mushroom edibles, such as chocolate bars and gummies, are a popular and approachable way to experience psilocybin. For those exploring edibles for the first time, a common question arises: How long do mushroom edibles take to kick in? The answer depends on several factors, including digestion, dosage, edible type, and individual metabolism. Understanding timing can help you approach your experience safely, confidently, and intentionally. Typical Onset Time for Mushroom Edibles Most people notice the first effects of mushroom edibles within 30–90 minutes after consumption. Onset can vary widely between individuals. A general timeline: 30–45 minutes: Very subtle sensations may begin 60–90 minutes: Effects become more noticeable 2–3 hours: Peak effects often occur 4–6 hours: Effects gradually taper off Because mushroom edibles must be digested before psilocybin is metabolized into psilocin (the compound that interacts with the brain), they generally take longer to kick in than capsules, tea, or other fast-absorbing formats. Why Edibles Take Longer to Kick In Edibles are absorbed through the digestive system, and this process can slow onset. Several factors influence timing: Stomach contents: A full stomach can delay onset, while an empty stomach may speed it up slightly Metabolism: Everyone’s digestive and liver metabolism differs, which can change how quickly effects are felt Edible type: Ingredients, sugar, and fat content affect how quickly the body breaks down the product Dosage: Larger doses increase intensity, not speed Because of these variables, two people consuming the same edible may experience very different onset times, even when consuming identical portions. Do Chocolate and Gummies Affect Timing? There is no consistent scientific evidence showing that chocolate or gummies reliably kick in faster or slower than one another. Both formats require digestion, and onset depends primarily on individual metabolism and stomach contents. Some users describe chocolate edibles as smoother or more gradual, while others notice no difference at all. These experiences are anecdotal and not a reliable predictor of timing. The takeaway: choose a format that feels manageable and familiar to you, not one based on assumptions about speed. What Dosage Affects Timing and Intensity? While dosage does not significantly change onset time, it strongly influences how noticeable the effects feel. Edibles that are pre-measured or segmented make dosing easier and safer. For example: Product Dose per piece Format EDEN Macrodose Gummies 0.40g Individual gummy EDEN Microdose Gummies 0.20g Individual gummy MycroChips Chocolate Bars 0.22g Segmented squares Hero Bars Varies per square Segmented chocolate NeauTropics Bars Varies per square Segmented chocolate Pre-measured formats allow users to gradually increase intake, monitor effects, and avoid accidental overconsumption. How Portion Size Influences the Experience Smaller portions don’t kick in faster, but they often lead to: A more gradual buildup Easier interpretation of early effects Greater control over total intake Larger portions may feel more intense once they begin and are less forgiving if taken all at once. Because edibles take time to digest, starting with clearly defined increments allows users to wait, assess effects, and decide whether to continue—rather than guessing in the first 30–60 minutes. Tips for a Safer, More Predictable Experience Start low and go slow: Begin with a smaller portion and wait at least 90 minutes before considering more. Space out doses: Give your body time to metabolize the psilocybin before taking more. Use pre-measured edibles: Products like EDEN Macrodose Gummies, MycroChip Chocolate, and Hero Chocolate reduce guesswork. Be mindful of meals: A lighter meal may slightly speed onset, while a heavy meal can delay it. Stay hydrated and comfortable: Water, a calm environment, and a relaxed mindset can improve the overall experience. Plan your setting: Being in a safe, familiar space helps users interpret effects more clearly, especially during the early onset period. Why Timing Matters Understanding the timing of mushroom edibles is less about rushing the effects and more about creating a controlled, safe experience. Because edibles have a delayed onset, the risk is often stacking doses too soon, which can lead to unexpected intensity. Pre-measured portions and patience help prevent this common issue. Final Thoughts Mushroom edibles are a slow-onset but approachable way to experience psilocybin. Timing varies depending on digestion, metabolism, and portion size, so patience is key. By using clearly measured edibles and following safe consumption practices, users can enjoy a more predictable and controlled experience.
Learn more
Frequently Asked Questions
What's the difference between microdosing and macrodosing?
What's the difference between microdosing and macrodosing?
Microdosing uses sub-perceptual amounts for daily wellness without psychedelic effects. Macrodosing produces full psychedelic experiences for deeper therapeutic work.
How should I store my mushrooms?
How should I store my mushrooms?
Keep them in an airtight container in a cool, dark place. Properly stored dried mushrooms maintain potency for months to over a year.
Can I build tolerance to psilocybin?
Can I build tolerance to psilocybin?
Yes, tolerance develops quickly but resets within a few days. This is why microdosing schedules include rest days between doses.
Which strain should I start with?
Which strain should I start with?
Golden Teacher is ideal for beginners due to its moderate potency and gentle effects. Start with lower doses regardless of strain choice.